Title |
Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation
|
---|---|
Published in |
Molecular Cancer, March 2013
|
DOI | 10.1186/1476-4598-12-22 |
Pubmed ID | |
Authors |
Mariana Toricelli, Fabiana HM Melo, Giovani B Peres, Débora CP Silva, Miriam G Jasiulionis |
Abstract |
Anoikis resistance is one of the abilities acquired along tumor progression. This characteristic is associated with metastasis development, since tumorigenic cells must survive independently of cell-matrix interactions in this process. In our laboratory, it was developed a murine melanocyte malignant transformation model associated with a sustained stressful condition. After subjecting melan-a melanocytes to 1, 2, 3 and 4 cycles of anchorage impediment, anoikis resistant cells were established and named 1C, 2C, 3C and 4C, respectively. These cells showed altered morphology and PMA independent cell growth, but were not tumorigenic, corresponding to pre-malignant cells. After limiting dilution of 4C pre-malignant cells, melanoma cell lines with different characteristics were obtained. Previous data from our group showed that increased Timp1 expression correlated with anoikis-resistant phenotype. Timp1 was shown to confer anchorage-independent growth capability to melan-a melanocytes and render melanoma cells more aggressive when injected into mice. However, the mechanisms involved in anoikis regulation by Timp1 in tumorigenic cells are not clear yet. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 61 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 15 | 24% |
Student > Ph. D. Student | 11 | 18% |
Researcher | 9 | 15% |
Student > Bachelor | 5 | 8% |
Professor | 5 | 8% |
Other | 9 | 15% |
Unknown | 8 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 20 | 32% |
Biochemistry, Genetics and Molecular Biology | 14 | 23% |
Medicine and Dentistry | 9 | 15% |
Neuroscience | 2 | 3% |
Arts and Humanities | 1 | 2% |
Other | 3 | 5% |
Unknown | 13 | 21% |